Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1056466

Clark Estates Inc/ny

Investment managerFiled 2026-08-05 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$433.7M
Reported positions
90
Top holdings a year, 3 yrs
+6.4%
Average holding period
2.0 yrs

Clark Estates Inc/ny is an investment manager that reported 90 positions worth $433.7M in its Q2 2026 13F, filed 2026-08-05. Its largest holdings were Ea Series Trust (ECML, 15.4%), Vanguard Ftse Developed Markets Index Fu (VEA, 6.1%), Unilever PLC (UL, 5.1%). A portfolio copying its top holdings returned 6.4% a year over the last 3 years, against 20.4% for the S&P 500.

Clark Estates Inc/ny holdings largest 50 of 90 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Clark Estates Inc/ny 13F holdings
Stock% of 13F valueShare changeReported value
ECMLEa Series Trust15.4%-18.7%$66.7M
VEAVanguard Ftse Developed Markets Index Fu6.1%—$26.4M
ULUnilever PLC5.1%+21.3%$22.2M
DISDisney Walt Co4.4%+0.0%$19.3M
AMRZAmrize Ltd Shs4.0%+14.0%$17.3M
SONYSony Group Corp3.8%+19.3%$16.5M
HLNHaleon PLC3.7%+21.4%$15.9M
SOLVSolventum Corporation Common S3.6%-31.0%$15.4M
BLCOBausch Plus Lomb Corp3.4%+6.8%$14.6M
WMGWarner Music Group Corp Cl A3.3%-17.7%$14.5M
HSICSchein Henry Inc Com2.6%—$11.3M
IQVIqvia Hldgs Inc2.3%-45.2%$10.1M
STTKShattuck Labs Inc2.3%-3.1%$9.9M
MDTMedtronic PLC1.6%-41.9%$7.0M
WLYWiley John & Sons Inc1.1%+40.9%$4.6M
DDD3d Sys Corp Del1.0%+0.0%$4.3M
SNNSmith & Nephew PLC ADR1.0%-34.8%$4.1M
MDPediatrix Medical Group Inc0.9%+18.6%$3.9M
INDVIndivior Pharmaceuticals Inc0.9%+0.0%$3.8M
CPRXCatalyst Pharmaceuticals Inc0.8%+0.0%$3.6M
HALOHalozyme Therapeutics Inc0.8%+0.0%$3.5M
MOAltria Group Inc0.8%+0.0%$3.5M
CROXCrocs Inc0.8%+0.0%$3.5M
BBYBest Buy Inc0.8%—$3.3M
BIIBBiogen Inc0.8%+0.0%$3.3M
GILDGilead Sciences Inc0.8%+0.0%$3.3M
JCOMZiff Davis Inc0.8%-10.4%$3.3M
STRAStrategic Ed Inc0.7%+53.3%$3.2M
WEXWex Inc0.7%+44.4%$3.1M
TDCTeradata Corp Del0.7%-10.3%$3.0M
WKCWorld Kinect Corporation0.7%—$3.0M
HRMYHarmony Biosciences Holdings I0.7%+0.0%$3.0M
FTDRFrontdoor Inc0.7%—$2.9M
AOSSmith A O Corp0.7%—$2.9M
DORMDorman Prods Inc0.7%+0.0%$2.9M
MTCHMatch Group Inc.0.7%+0.0%$2.8M
INCYIncyte Corp0.7%+0.0%$2.8M
EXPEExpedia Group Inc0.6%-0.9%$2.8M
ADUSAddus Homecare Corp0.6%—$2.8M
VTRSViatris Inc0.6%+0.0%$2.7M
GNTXGentex Corp0.6%—$2.7M
TNETTrinet Group Inc0.6%—$2.6M
CDWCdw Corp/de0.6%+0.0%$2.6M
OSPNOnespan Inc0.6%—$2.5M
BMYBristol-Myers Squibb Co0.6%+0.0%$2.5M
OPCHOption Care Health Inc0.6%—$2.5M
MMSMaximus Inc0.6%—$2.5M
KFYKorn-Ferry Com0.6%+0.0%$2.5M
RCIIUpbound Group Inc0.6%—$2.4M
KBRKbr Inc0.6%—$2.4M

What Clark Estates Inc/ny bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+8.1% /yr
S&P 500 +20.1%
3 years
+6.4% /yr
S&P 500 +20.4%
5 years
-0.3% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$433.7M90
Q1 2026$416.2M97
Q4 2025$412.1M98
Q3 2025$437.7M99
Q2 2025$445.7M97
Q1 2025$472.3M94
Q4 2024$517.4M92
Q3 2024$537.3M90
Q2 2024$532.5M86
Q1 2024$607.1M88
Q4 2023$590.3M88
Q3 2023$549.6M90

Questions about Clark Estates Inc/ny's portfolio

What stocks does Clark Estates Inc/ny own?

Clark Estates Inc/ny's latest 13F, for Q2 2026 and filed Aug 5, 2026, lists 90 positions worth $433.7M. The largest are Ea Series Trust (ECML) at 15.4%, Vanguard Ftse Developed Markets Index Fu (VEA) at 6.1%, Unilever PLC (UL) at 5.1%, Disney Walt Co (DIS) at 4.4% and Amrize Ltd Shs (AMRZ) at 4.0%.

What did Clark Estates Inc/ny buy last quarter?

In Q2 2026, Clark Estates Inc/ny added Strategic Ed Inc (STRA) (+53.3% shares), Wex Inc (WEX) (+44.4% shares) and Wiley John & Sons Inc (WLY) (+40.9% shares), compared with its Q1 2026 filing.

What did Clark Estates Inc/ny sell last quarter?

In Q2 2026, Clark Estates Inc/ny cut from its top 50 Avanos Med Inc (AVNS), cut from its top 50 Lantheus Hldgs Inc (LNTH), cut from its top 50 TD SYNNEX Corp (SNX), cut from its top 50 NetScout Systems, Inc. (NTCT), cut from its top 50 Pfizer Inc (PFE), Iqvia Hldgs Inc (IQV) (-45.2% shares), Medtronic PLC (MDT) (-41.9% shares) and Smith & Nephew PLC ADR (SNN) (-34.8% shares), compared with its Q1 2026 filing.

How has Clark Estates Inc/ny's portfolio performed?

A portfolio copying Clark Estates Inc/ny's 20 largest 13F holdings each quarter, from the day each filing was public, returned +6.4% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +8.1% against +20.1%. Over 5 years: -0.3% a year against +11.6%.

When is Clark Estates Inc/ny's next 13F filing due?

13F filings are due 45 days after each quarter ends. Clark Estates Inc/ny's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.